JP2017519817A - 抗菌薬としての金（ｉ）−ホスフィン化合物 - Google Patents

抗菌薬としての金（ｉ）−ホスフィン化合物 Download PDF

Info

Publication number
JP2017519817A
JP2017519817A JP2017514984A JP2017514984A JP2017519817A JP 2017519817 A JP2017519817 A JP 2017519817A JP 2017514984 A JP2017514984 A JP 2017514984A JP 2017514984 A JP2017514984 A JP 2017514984A JP 2017519817 A JP2017519817 A JP 2017519817A
Authority
JP
Japan
Prior art keywords
compound
biofilm
microorganisms
compound according
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017514984A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017519817A5 (enExample
Inventor
イアン・ホルムズ
アラン・ネイラー
ガブリエル・ネゴイタ−ギラス
ジョナサン・パウエル
イアン・チャールズ
ダグマー・アルバー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Auspherix Ltd
Original Assignee
Auspherix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1409401.5A external-priority patent/GB201409401D0/en
Priority claimed from GB201501969A external-priority patent/GB201501969D0/en
Application filed by Auspherix Ltd filed Critical Auspherix Ltd
Publication of JP2017519817A publication Critical patent/JP2017519817A/ja
Publication of JP2017519817A5 publication Critical patent/JP2017519817A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/08—Materials for coatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/59—Hydrogenated pyridine rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503—Five-membered rings
    • C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
    • C07F9/65068—Five-membered rings having the nitrogen atoms in positions 1 and 3 condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/650905—Six-membered rings having the nitrogen atoms in the positions 1 and 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/6512—Six-membered rings having the nitrogen atoms in positions 1 and 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Inorganic Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
JP2017514984A 2014-05-28 2015-05-28 抗菌薬としての金（ｉ）−ホスフィン化合物 Pending JP2017519817A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB1409401.5A GB201409401D0 (en) 2014-05-28 2014-05-28 Anti-bacterial compounds
GB1409401.5 2014-05-28
GB1501969.8 2015-02-06
GB201501969A GB201501969D0 (en) 2015-02-06 2015-02-06 Anti-bacterial compounds
PCT/GB2015/051550 WO2015181550A1 (en) 2014-05-28 2015-05-28 Gold (i)-phosphine compounds as anti-bacterial agents

Publications (2)

Publication Number Publication Date
JP2017519817A true JP2017519817A (ja) 2017-07-20
JP2017519817A5 JP2017519817A5 (enExample) 2018-06-21

Family

ID=53284305

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017514984A Pending JP2017519817A (ja) 2014-05-28 2015-05-28 抗菌薬としての金（ｉ）−ホスフィン化合物

Country Status (12)

Country Link
US (1) US20170204123A1 (enExample)
EP (1) EP3148554A1 (enExample)
JP (1) JP2017519817A (enExample)
KR (1) KR20170012288A (enExample)
CN (1) CN106459116A (enExample)
AU (1) AU2015265714A1 (enExample)
CA (1) CA2950384A1 (enExample)
EA (1) EA201692190A1 (enExample)
IL (1) IL249176A0 (enExample)
MX (1) MX2016015625A (enExample)
SG (1) SG11201609377TA (enExample)
WO (1) WO2015181550A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021536431A (ja) * 2018-08-16 2021-12-27 ユニヴェルシテット・ヤジェロンスキ 生体分子のコンジュゲーションの方法及び生体分子複合体形成のための金ドナーの新たな使用

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008143889A1 (en) 2007-05-14 2008-11-27 Research Foundation Of State University Of New York Induction of a physiological dispersion response in bacterial cells in a biofilm
WO2016124936A1 (en) * 2015-02-06 2016-08-11 Auspherix Limited Inhibition of microbial persister cells
EP3346840A4 (en) * 2015-09-08 2019-03-13 Nanyang Technological University PROCESS FOR INHIBITING THE QUORUM DETECTION IN PSEUDOMONAS AERUGINOSA
GB201521238D0 (en) * 2015-12-02 2016-01-13 Auspherix Ltd Anti-bacterial compounds
GB201708844D0 (en) * 2017-06-02 2017-07-19 Auspherix Ltd Anti-bacterial compounds
CN109369482B (zh) * 2018-12-07 2020-08-28 济源市万洋华康生物科技有限公司 一种l-硒代胱氨酸的制备方法
CN113135958B (zh) * 2021-04-08 2022-05-27 南京中医药大学 氮杂环卡宾硒-金化合物在制备抗耐碳青霉烯类鲍曼不动杆菌药物中的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5041859A (enExample) * 1973-08-01 1975-04-16
WO1995014703A1 (en) * 1993-11-24 1995-06-01 Luminis Pty. Ltd. Triorganophosphinegold (i) thionucleobases with anti-tumor activity

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5041859A (enExample) * 1973-08-01 1975-04-16
WO1995014703A1 (en) * 1993-11-24 1995-06-01 Luminis Pty. Ltd. Triorganophosphinegold (i) thionucleobases with anti-tumor activity

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
"A Gold(I) Mononuclear Complex and Its Association into Binuclear and Cluster Compounds by Hydrog", INORGANIC CHEMISTRY, vol. 39(24), JPN6018052179, 2000, pages 5520 - 5529, ISSN: 0003953054 *
"Antiarthritic activity in rats of some phosphinegold(I) thionucleobases and related thiolates", METAL-BASED DRUGS, vol. 5(4), JPN6018052177, 1998, pages 245 - 249, ISSN: 0003953052 *
"Correlation of the in vitro cytotoxic and in vivo antitumor activities of gold(I) coordination c", JOURNAL OF MEDICINAL CHEMISTRY, vol. 29(2), JPN6018052174, 1986, pages 218 - 23, ISSN: 0003953050 *
"Exploration on Au(S-4-py)PR3 complexes as a viable building block for constructing hetero-nuclea", JOURNAL OF ORGANOMETALLIC CHEMISTRY, vol. 690(1), JPN6018052172, 2005, pages 48 - 56, ISSN: 0003953049 *
"Gold complexes with heterocyclic thiones as ligands. X-ray structure determination of [Au(C5H5N", JOURNAL OF THE CHEMICAL SOCIETY, DALTON TRANSACTIONS: INORGANIC CHEMISTRY (1972-1999), vol. (11), JPN6018052178, 1990, pages 3457 - 63, ISSN: 0003953053 *
"Mechanistic studies of reactions of benzenethiol with methyl derivatives of platinum(II) and gol", JOURNAL OF THE CHEMICAL SOCIETY, DALTON TRANSACTIONS: INORGANIC CHEMISTRY (1972-1999), vol. (2), JPN6018052176, 1975, pages 115 - 20, ISSN: 0003953051 *
"Platinum(II), palladium(II), nickel(II), and gold(I) complexes of the "electrospray-friendly" th", JOURNAL OF COORDINATION CHEMISTRY, vol. 63(17), JPN6018052169, 2010, pages 2965 - 2975, ISSN: 0004101709 *
"Synthesis, single crystal X-ray analysis, and TEM for a single-sized Au11 cluster stabilized by", JOURNAL OF ORGANOMETALLIC CHEMISTRY, vol. 691(4), JPN6018052171, 2006, pages 638 - 642, ISSN: 0003953048 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021536431A (ja) * 2018-08-16 2021-12-27 ユニヴェルシテット・ヤジェロンスキ 生体分子のコンジュゲーションの方法及び生体分子複合体形成のための金ドナーの新たな使用
JP7199512B2 (ja) 2018-08-16 2023-01-05 ユニヴェルシテット・ヤジェロンスキ 生体分子のコンジュゲーションの方法及び生体分子複合体形成のための金ドナーの新たな使用

Also Published As

Publication number Publication date
SG11201609377TA (en) 2016-12-29
CA2950384A1 (en) 2015-12-03
EA201692190A1 (ru) 2017-03-31
MX2016015625A (es) 2017-07-28
EP3148554A1 (en) 2017-04-05
CN106459116A (zh) 2017-02-22
KR20170012288A (ko) 2017-02-02
IL249176A0 (en) 2017-01-31
WO2015181550A1 (en) 2015-12-03
US20170204123A1 (en) 2017-07-20
AU2015265714A1 (en) 2016-11-24

Similar Documents

Publication Publication Date Title
JP2017529357A (ja) 抗菌薬としての金（ｉ）−ホスフィン化合物
JP2017519817A (ja) 抗菌薬としての金（ｉ）−ホスフィン化合物
EP3040076B1 (en) A composition comprising a non-peptide antibiotic and cysteamine
JP2016509584A (ja) 抗菌性組成物
WO2017093545A1 (en) Anti-bacterial compounds based on amino-gold phosphine complexes
JP2019502667A (ja) 抗菌化合物
US20180020669A1 (en) Methods for the Inhibition and Dispersal of Biofilms
WO2017093544A1 (en) Alkynyl phosphine gold complexes for treating bacterial infections
JP2025519511A (ja) 一酸化窒素放出化合物を含む多成分医薬組成物及びキット、並びにその使用方法
WO2018220171A1 (en) Gold compounds and their use in therapy
HK1220911B (en) A composition comprising a non-peptide antibiotic and cysteamine
HK1185015B (en) A composition comprising an antibiotic and a dispersant

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180509

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180509

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20181220

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190108

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20190827